Time dependencies in perfluorooctylacids disposition in rat and monkeys: a kinetic analysis.

Perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) are surfactants that have been used for various industrial and consumer applications. The widespread exposure and persistence of PFOA and PFOS in humans have caused these chemicals to be the subject of intense kinetic and toxicity studies. To identify the biological determinants of the species different in elimination observed in kinetic studies, we incorporated time-dependent descriptions for free fraction in plasma and for volume of distribution into an earlier pharmacokinetic model to simulate the time course behaviors of PFOA and PFOS in monkeys and rats. The structurally similar model for monkeys and rats also allows for examination of the complex kinetics observed in animal studies. A higher estimated liver:blood partition coefficient in the rat and additional binding in rat liver suggest that PFOS retention in liver occurs in rats but not in monkeys. Higher liver:blood partition coefficient and renal filtration suggest that PFOS is retained longer in tissues compared to PFOA. A much lower renal resorption may explain the fast elimination of PFOA from plasma observed in female compared to male rats. Understanding these cross-species, cross-compound, and cross-gender difference is an important step in the future development of a human model for these compounds.

[1]  A. Seacat,et al.  Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. , 2004, Chemical research in toxicology.

[2]  K. Melmon,et al.  Normal distribution of cardiac output in the unanesthetized, restrined rhesus monkey. , 1968, Journal of applied physiology.

[3]  Jeffrey H Mandel,et al.  Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. , 2003, Environmental science & technology.

[4]  Kouji Harada,et al.  The Influence of Time, Sex and Geographic Factors on Levels of Perfluorooctane Sulfonate and Perfluorooctanoate in Human Serum over the Last 25 years , 2004, Journal of occupational health.

[5]  I. Chahoud,et al.  Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin , 1989, Archives of Toxicology.

[6]  K. Helzlsouer,et al.  Historical Comparison of Perfluorooctanesulfonate, Perfluorooctanoate, and Other Fluorochemicals in Human Blood , 2005, Environmental health perspectives.

[7]  M. Andersen,et al.  Dose-response modeling of cytochrome p450 induction in rats by octamethylcyclotetrasiloxane. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  D. Neubert,et al.  Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin , 1988, Archives of Toxicology.

[9]  P. Hinderliter,et al.  Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  Jeffrey H Mandel,et al.  Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.

[11]  C. Elcombe,et al.  Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  C. Lau,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  H. D. Patton,et al.  Physiology and biophysics , 1965 .

[14]  Jeffrey H Mandel,et al.  Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. , 2004, Chemosphere.

[15]  G. Carrier,et al.  Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/PCDFs. , 1995, Toxicology and applied pharmacology.

[16]  A. Calafat,et al.  Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. , 2006, Environmental science & technology.

[17]  G. Carrier,et al.  Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissues. , 1995, Toxicology and applied pharmacology.

[18]  M E Andersen,et al.  Development of a physiologically based pharmacokinetic model for chloroform. , 1990, Toxicology and applied pharmacology.

[19]  N. Kudo,et al.  Sex hormone-regulated renal transport of perfluorooctanoic acid. , 2002, Chemico-biological interactions.

[20]  R. Renner.  Growing concern over perfluorinated chemicals. , 2001, Environmental science & technology.

[21]  Paul D. Jones,et al.  Accumulation of perfluorooctane sulfonate in marine mammals. , 2001, Environmental science & technology.

[22]  G. Olsen,et al.  Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.

[24]  F. Benoit,et al.  A pilot study on the determination of perfluorooctanesulfonate and other perfluorinated compounds in blood of Canadians. , 2004, Journal of environmental monitoring : JEM.

[25]  Harvey J Clewell,et al.  Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles. , 2005, Environmental science & technology.

[26]  M E Andersen,et al.  Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation. , 1997, Toxicology and applied pharmacology.

[27]  R. Conolly,et al.  Analysis of respiratory exchange of methanol in the lung of the monkey using a physiological model. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  J. Giesy,et al.  Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.

[29]  Harvey J Clewell,et al.  Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives. , 2006, Toxicology.

[30]  M. A. Mohd,et al.  Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. , 2004, Environmental science & technology.